Humana’s monopolisation suit against Mallinckrodt moves forward
Humana has sufficiently alleged that Mallinckrodt illegally maintained a monopoly over treatment for infant seizures by purchasing rights to a potential substitute, a California federal court has ruled.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10